USC Alzheimer’s experts at AAIC

July 19, 2018

As a research institution devoted to promoting life span health, USC has more than
70 researchers dedicated to the prevention, treatment and potential cure of Alzheimer’s disease. The memory-erasing illness is one of the greatest health challenges of the century, affecting 1 in 3 seniors and costing $277 billion a year in health care services. USC researchers across a range of disciplines are examining the health, societal and political effects and implications of the disease.

At the Alzheimer’s Association International Conference (AAIC), preliminary results of the A4 Study will be presented by the project director, Dr. Reisa Sperling of Harvard Medical School. Dr. Sperling and Dr. Paul Aisen of the Keck School of Medicine of USC are the principal investigators on the study. 

Contact: Jeremy Pepper at (213) 740-8606 or pepper@usc.edu

Paul Aisen of the Alzheimer’s Therapeutic Research Institute

Paul Aisen is director of the Alzheimer’s Therapeutic Research Institute (ATRI) of the Keck School of Medicine of USC, and is a professor of neurology at the Keck School of Medicine of USC. Aisen has been a leading figure in Alzheimer’s disease research for more than two decades; he has developed novel methodologies and designed and directed many large therapeutic trials.

Aisen will be presenting at pre-conference workshops and conference sessions at AAIC; a schedule is available upon request. He is available to speak with the media on the preliminary results of the A4 Study, as well as the Alzheimer’s Clinical Trial Consortium (ACTC), a national Alzheimer’s research system.

The ACTC leadership team is comprised of Paul Aisen, Ronald Petersen from Mayo Clinic in Minnesota and Reisa Sperling from Brigham and Women’s Hospital and Massachusetts General Hospital — both Harvard-affiliated hospitals in Boston.

Contact: (858) 964-1411 or paisen@usc.edu

Arthur Toga of the Laboratory of Neuro Imaging

Arthur W. Toga is an American neuroscientist and the director of the Laboratory of Neuro Imaging (LONI) and the USC Mark and Mary Stevens Neuroimaging and Informatics Institute at the Keck School of Medicine of USC. He is also the Ghada Irani Chair in Neuroscience and provost professor of ophthalmology, neurology, psychiatry and the behavioral sciences, radiology and engineering.

Toga has been at the leading edge of the complex frontier of brain imaging for over two decades, with his research focusing on neuroimaging, informatics, mapping brain structure and function, and brain atlasing.

His work in informatics includes the development and implementation of some of the largest and most widely used databases and data mining tools linking disparate data from genetics, imaging, clinical and behavior, supporting global efforts in Alzheimer’s disease, Huntington’s and Parkinson’s disease.

At AAIC, Toga will be presenting on Apoe and Sex Differences on Alzheimer’s Disease Risk, as well as other pre-conference workshops and conference sessions. A schedule is available upon request.

Contact: (323) 442-7246 or toga@loni.usc.edu

Michael Donohue of the Alzheimer’s Therapeutic Research Institute

Michael Donohue is associate professor of neurology at the Keck School of Medicine of USC, and Associate Director of Biostatistics at USC ATRI. His research includes developing the statistical methodology required to model the long-term evolution of Alzheimer’s disease from symptom-free to dementia. He also works on the design of clinical trials and outcome measures for the prevention and treatment of Alzheimer’s disease.

Donohue will be presenting at pre-conference workshops and conference sessions – a schedule is available upon request – and is available for interviews.

Contact: (858) 964-0790 or mdonohue@usc.edu